Securities Code: 300233
Securities Abbreviation: Jincheng Pharmaceutical
Announcement No.: 2026-050
Shandong Jincheng Pharmaceutical Group Co., Ltd.
Announcement on Subsidiary Receiving Drug Registration Certificate
The company and all members of the board of directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and there are no false records, misleading statements, or major omissions.
Beijing Jincheng Taier Pharmaceutical Co., Ltd. (hereinafter referred to as "Jincheng Taier"), a wholly-owned subsidiary of Shandong Jincheng Pharmaceutical Group Co., Ltd., recently received the "Drug Registration Certificate" for "Inosine Adenosine Disuccinate for Injection" issued by the National Medical Products Administration. This product is deemed to have passed the consistency evaluation for generic drugs. The main contents are announced as follows:
I. Main Contents of the Certificate